We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Catalent Expands Cell Therapy Reach With Belgian Purchase
Catalent Expands Cell Therapy Reach With Belgian Purchase
Catalent is expanding its cell therapy product line by adding ALLOB, an investigational product derived from bone marrow cells, through the purchase of Bone Therapeutics’ cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support (SCTS).